Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2014-05-15 17:09:52
Reporting Period:
Filing Date:
Accepted Time:
2014-05-15 17:09:52
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1423824 Alder Biopharmaceuticals Inc ALDR Pharmaceutical Preparations (2834) 000000000
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1599970 Partnership Limited 8 West Ventures C/o Five Corners Capital
700 W. Georgia Street, Suite 2500
Vancouver A1 V7Y1B3
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-05-13 3,219,528 $0.00 3,219,528 No 4 C Direct
Common Stock Acquisiton 2014-05-13 250,000 $10.00 3,469,528 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2014-05-13 1,027,668 $0.00 1,027,668 $0.00
Common Stock Series B Preferred Stock Disposition 2014-05-13 853,146 $0.00 853,146 $0.00
Common Stock Series C Preferred Stock Disposition 2014-05-13 841,750 $0.00 841,750 $0.00
Common Stock Series D Preferred Stock Disposition 2014-05-13 496,964 $0.00 496,964 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
  1. The preferred stock converted into common stock on a 1-for-1 basis upon the closing of the issuer's initial public offering and had no expiration date.